Literature DB >> 19334079

Platelet activity and outcome after intracerebral hemorrhage.

Andrew M Naidech1, Richard A Bernstein, Kimberly Levasseur, Sarice L Bassin, Bernard R Bendok, H Hunt Batjer, Thomas P Bleck, Mark J Alberts.   

Abstract

There are few data on platelet function in intracerebral hemorrhage (ICH). We prospectively enrolled 69 patients with ICH and measured platelet function on admission. Aspirin use before ICH was associated with reduced platelet activity. Less platelet activity was associated with intraventricular hemorrhage (516.5 [interquartile range (IQR), 454-629.25] vs 637 [IQR, 493-654] aspirin reaction units; p = 0.04) and death at 14 days (480.5 [IQR, 444.5-632.5] vs 626 [IQR, 494-652] aspirin reaction units; p = 0.04). Objective measures of platelet function on admission are associated with intraventricular hemorrhage and death after ICH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19334079     DOI: 10.1002/ana.21618

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  26 in total

1.  The slippery slope of platelet transfusion for intracerebral hemorrhage.

Authors:  Wendy C Ziai; Marek A Mirski
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

2.  Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage.

Authors:  Michael Moussouttas
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

3.  Medication History versus Point-of-Care Platelet Activity Testing in Patients with Intracerebral Hemorrhage.

Authors:  Matthew B Maas; Andrew M Naidech; Minjee Kim; Ayush Batra; Edward M Manno; Farzaneh A Sorond; Shyam Prabhakaran; Eric M Liotta
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-01-05       Impact factor: 2.136

4.  Is platelet activity important in acute intracerebral hemorrhage?

Authors:  Christine A C Wijman
Journal:  Neurocrit Care       Date:  2009-08-28       Impact factor: 3.210

5.  Case scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary intervention.

Authors:  Bhiken I Naik; Ellen C Keeley; Daryl R Gress; Zhiyi Zuo
Journal:  Anesthesiology       Date:  2014-09       Impact factor: 7.892

6.  Emergency Neurological Life Support: Intracerebral Hemorrhage.

Authors:  J Claude Hemphill; Arthur Lam
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

Review 7.  Emergency Neurological Life Support: Intracerebral Hemorrhage.

Authors:  Edward C Jauch; Jose A Pineda; J Claude Hemphill
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

8.  Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage.

Authors:  Andrew M Naidech; Sarice L Bassin; Richard A Bernstein; H Hunt Batjer; Mark J Alberts; Paul F Lindholm; Thomas P Bleck
Journal:  Neurocrit Care       Date:  2009-12       Impact factor: 3.210

Review 9.  Emergency neurological life support: intracerebral hemorrhage.

Authors:  Charles M Andrews; Edward C Jauch; J Claude Hemphill; Wade S Smith; Scott D Weingart
Journal:  Neurocrit Care       Date:  2012-09       Impact factor: 3.210

10.  Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage.

Authors:  Michael Moussouttas; Rishi Malhotra; Luis Fernandez; Mitchell Maltenfort; Melissa Holowecki; Jennifer Delgado; Nadine Lawson; Neeraj Badjatia
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.